Top Markets
#1 Tutorial Tutorial +33.20%
#2 Official Trump Official Trump +31.91%
#3 Siacoin Siacoin +22.47%
#4 Mubarak Mubarak +21.86%
#5 EXOD EXOD +18.93%
#6 Pump.fun Pump.fun +18.81%
#7 Unit Pump Unit Pump +18.81%
#8 MowCat MowCat +18.56%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +18.54%
#10 Melania Meme Melania Meme +18.10%
Coin of the day
Tutorial Tutorial
設定
言語
日本
通貨
USD
テーマ
Abliva AB (publ) Abliva AB (publ)

Abliva AB (publ)

ABLI
株式のランク #22998
Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000,... Abliva AB (publ), a Swedish biopharmaceutical company founded in Lund in 2000, focuses on developing innovative therapeutic solutions for primary mitochondrial diseases. Its pipeline includes KL1333, currently in Phase 2/3 clinical trials for the long-term management of these conditions, and NV354, which is preparing for clinical studies targeting primary mitochondrial diseases specifically linked to Complex I deficiency. The company is also advancing NeuroSTAT through a Phase 1b/2a clinical study for the treatment of traumatic brain injury. Abliva maintains strategic partnerships with entities such as Isomerase, Yungjin Pharm, the University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The firm rebranded as Abliva AB (publ) in May 2020, having previously been known as NeuroVive Pharmaceutical AB (publ).
株価
$0.04959193
最終同期: 2025-03-17
時価総額
$79.94M
変化（1日）
13.49%
変化（1年）
0.00%
国
SE
取引 Abliva AB (publ) (ABLI)

カテゴリー

Healthcare
Abliva AB (publ)（ABLI）の利益
2026 時点の利益 TTM: 0
Abliva AB (publ) の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Abliva AB (publ) の利益の推移（2026 〜 2026）
各年末の利益
年 利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH